Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Knobbe-Thomsen Cb"'
Publikováno v:
Joint-Meeting of the German Society for Neuropathology and Neuroanatomy (DGNN) and the Scandinavian Neuropathological Society (SNS); 20160922-20160924; Hamburg; DOC16dgnnP39 /20160914/
Questions: In 2010 Noushmehr and coworkers showed that IDH1 mutations are associated with a CpG island methylator phenotype (CIMP) in glioma [ref:1]. This phenotype is accompanied with longer overall survival, but its molecular role and function rema
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d11f23fa316cf026e86f11eff36d943
Publikováno v:
Joint-Meeting of the German Society for Neuropathology and Neuroanatomy (DGNN) and the Scandinavian Neuropathological Society (SNS); 20160922-20160924; Hamburg; DOC16dgnnP42 /20160914/
Question: It has already been shown that cannabinoids have anti-tumorous effects against malignant gliomas. Cannabinoids activate the receptors TRPV1, TRPV2, CB1 and CB2 in the CNS, which are summarized as the receptors of the endogenous cannabinoid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b92d5ff6c2561f7d31d18b238b26ad0c
Publikováno v:
Joint-Meeting of the German Society for Neuropathology and Neuroanatomy (DGNN) and the Scandinavian Neuropathological Society (SNS); 20160922-20160924; Hamburg; DOC16dgnnP37 /20160914/
Diffuse gliomas are the most frequent primary brain tumors and have an unpredictable rate of progression. It has been shown that malignant transformation of glial progenitor cells is associated with a number of genetic events, including p53 mutations
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92ceb6a8c6c7bad19782151ea47b2c03
Autor:
Antje Gohla, Knobbe-Thomsen Cb, Andreas Beilhack, Camelia M. Monoranu, Guido Reifenberger, Zink Tg, O. Fedorchenko, Stefanie Schwinn, Elisabeth Jeanclos, Markus Schulze, Anna-Leena Sirén, Sabrina Kraus
Publikováno v:
Oncogene. 35(24)
Glioblastoma is the most aggressive primary brain tumor in adults. Although the rapid recurrence of glioblastomas after treatment is a major clinical challenge, the relationships between tumor growth and intracerebral spread remain poorly understood.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f9a4cb22db698c4a4834f053022b1a4
https://pubmed.ncbi.nlm.nih.gov/26549022
https://pubmed.ncbi.nlm.nih.gov/26549022
Autor:
Marquardt V; Division of Pediatric Neuro-Oncogenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany, and German Cancer Consortium (DKTK), partner site Essen/Düsseldorf, Düsseldorf, Germany.; Institute of Pharmaceutical and Medicinal Chemistry, Heinrich Heine University Düsseldorf, Düsseldorf, Germany., Theruvath J; Department of Neurosurgery, Institute for StemCell Biology and Regenerative Medicine and Division of Pediatric Neurosurgery, Lucile Packard Children's Hospital, Stanford University, Stanford, California, USA.; Stanford University School of Medicine, Stanford, California, USA., Pauck D; Division of Pediatric Neuro-Oncogenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany, and German Cancer Consortium (DKTK), partner site Essen/Düsseldorf, Düsseldorf, Germany.; Department of Pediatric Oncology, Hematology, and Clinical Immunology, Medical Faculty, University Hospital Düsseldorf, Düsseldorf, Germany; and DKTK, partner site Essen/Düsseldorf, Germany, Düsseldorf, Germany., Picard D; Division of Pediatric Neuro-Oncogenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany, and German Cancer Consortium (DKTK), partner site Essen/Düsseldorf, Düsseldorf, Germany.; Department of Pediatric Oncology, Hematology, and Clinical Immunology, Medical Faculty, University Hospital Düsseldorf, Düsseldorf, Germany; and DKTK, partner site Essen/Düsseldorf, Germany, Düsseldorf, Germany., Qin N; Division of Pediatric Neuro-Oncogenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany, and German Cancer Consortium (DKTK), partner site Essen/Düsseldorf, Düsseldorf, Germany.; Department of Pediatric Oncology, Hematology, and Clinical Immunology, Medical Faculty, University Hospital Düsseldorf, Düsseldorf, Germany; and DKTK, partner site Essen/Düsseldorf, Germany, Düsseldorf, Germany., Blümel L; Division of Pediatric Neuro-Oncogenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany, and German Cancer Consortium (DKTK), partner site Essen/Düsseldorf, Düsseldorf, Germany.; Department of Pediatric Oncology, Hematology, and Clinical Immunology, Medical Faculty, University Hospital Düsseldorf, Düsseldorf, Germany; and DKTK, partner site Essen/Düsseldorf, Germany, Düsseldorf, Germany., Maue M; Division of Pediatric Neuro-Oncogenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany, and German Cancer Consortium (DKTK), partner site Essen/Düsseldorf, Düsseldorf, Germany.; Department of Pediatric Oncology, Hematology, and Clinical Immunology, Medical Faculty, University Hospital Düsseldorf, Düsseldorf, Germany; and DKTK, partner site Essen/Düsseldorf, Germany, Düsseldorf, Germany., Bartl J; Division of Pediatric Neuro-Oncogenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany, and German Cancer Consortium (DKTK), partner site Essen/Düsseldorf, Düsseldorf, Germany.; Department of Pediatric Oncology, Hematology, and Clinical Immunology, Medical Faculty, University Hospital Düsseldorf, Düsseldorf, Germany; and DKTK, partner site Essen/Düsseldorf, Germany, Düsseldorf, Germany., Ahmadov U; Division of Pediatric Neuro-Oncogenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany, and German Cancer Consortium (DKTK), partner site Essen/Düsseldorf, Düsseldorf, Germany.; Institute of Neuropathology, Medical Faculty, Heinrich-Heine University Düsseldorf, Düsseldorf; and DKTK, partner site Essen/Düsseldorf, Germany, Düsseldorf, Germany., Langini M; Division of Pediatric Neuro-Oncogenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany, and German Cancer Consortium (DKTK), partner site Essen/Düsseldorf, Düsseldorf, Germany.; Molecular Proteomics Laboratory, Biomedical Research Centre (BMFZ), Heinrich-Heine University, Düsseldorf, Germany, Düsseldorf, Germany., Meyer FD; Division of Pediatric Neuro-Oncogenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany, and German Cancer Consortium (DKTK), partner site Essen/Düsseldorf, Düsseldorf, Germany.; Institute of Neuropathology, Medical Faculty, Heinrich-Heine University Düsseldorf, Düsseldorf; and DKTK, partner site Essen/Düsseldorf, Germany, Düsseldorf, Germany., Cole A; Pediatrics, University of Colorado Denver, Aurora, Colorado, USA., Cruz-Cruz J; Pediatrics, University of Colorado Denver, Aurora, Colorado, USA., Graef CM; Department of Neurosurgery, Institute for StemCell Biology and Regenerative Medicine and Division of Pediatric Neurosurgery, Lucile Packard Children's Hospital, Stanford University, Stanford, California, USA., Wölfl M; Department of Pediatric Oncology, University Children's Hospital Würzburg, Würzburg, Germany., Milde T; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Department of Pediatric Hematology and Oncology, Heidelberg University Hospital, Heidelberg, Germany., Witt O; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany., Erdreich-Epstein A; Division of Hematology-Oncology and Blood and Marrow Transplantation, Department of Pediatrics and the Department of Pathology, Children's Hospital Los Angeles, and the Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, California, USA., Leprivier G; Institute of Neuropathology, Medical Faculty, Heinrich-Heine University Düsseldorf, Düsseldorf; and DKTK, partner site Essen/Düsseldorf, Germany, Düsseldorf, Germany., Kahlert U; Department of Neurosurgery, Medical Faculty, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany., Stefanski A; Molecular Proteomics Laboratory, Biomedical Research Centre (BMFZ), Heinrich-Heine University, Düsseldorf, Germany, Düsseldorf, Germany., Stühler K; Molecular Proteomics Laboratory, Biomedical Research Centre (BMFZ), Heinrich-Heine University, Düsseldorf, Germany, Düsseldorf, Germany., Keir ST; Department of Neurosurgery, Duke University, Durham, North Carolina, USA.; Preston Robert Tisch Brain Tumor Center, Duke University, Durham, North Carolina, USA., Bigner DD; Department of Neurosurgery, Duke University, Durham, North Carolina, USA.; Preston Robert Tisch Brain Tumor Center, Duke University, Durham, North Carolina, USA., Hauer J; Department of Pediatric Oncology, Hematology, and Clinical Immunology, Medical Faculty, University Hospital Düsseldorf, Düsseldorf, Germany; and DKTK, partner site Essen/Düsseldorf, Germany, Düsseldorf, Germany., Beez T; Department of Neurosurgery, Medical Faculty, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany., Knobbe-Thomsen CB; Institute of Neuropathology, Medical Faculty, Heinrich-Heine University Düsseldorf, Düsseldorf; and DKTK, partner site Essen/Düsseldorf, Germany, Düsseldorf, Germany., Fischer U; Department of Pediatric Oncology, Hematology, and Clinical Immunology, Medical Faculty, University Hospital Düsseldorf, Düsseldorf, Germany; and DKTK, partner site Essen/Düsseldorf, Germany, Düsseldorf, Germany., Felsberg J; Institute of Neuropathology, Medical Faculty, Heinrich-Heine University Düsseldorf, Düsseldorf; and DKTK, partner site Essen/Düsseldorf, Germany, Düsseldorf, Germany., Hansen FK; Institute of Pharmaceutical and Medicinal Chemistry, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.; Pharmaceutical/Medicinal Chemistry, Institute of Pharmacy, Leipzig University, Leipzig, Germany., Vibhakar R; Pediatrics, University of Colorado Denver, Aurora, Colorado, USA., Venkatraman S; Pediatrics, University of Colorado Denver, Aurora, Colorado, USA., Cheshier SH; Department of Neurosurgery, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA., Reifenberger G; Division of Pediatric Neuro-Oncogenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany, and German Cancer Consortium (DKTK), partner site Essen/Düsseldorf, Düsseldorf, Germany.; Institute of Neuropathology, Medical Faculty, Heinrich-Heine University Düsseldorf, Düsseldorf; and DKTK, partner site Essen/Düsseldorf, Germany, Düsseldorf, Germany., Borkhardt A; Division of Pediatric Neuro-Oncogenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany, and German Cancer Consortium (DKTK), partner site Essen/Düsseldorf, Düsseldorf, Germany.; Department of Pediatric Oncology, Hematology and Clinical Immunology, Medical Faculty, Heinrich-Heine-University, Düsseldorf, Germany., Kurz T; Institute of Pharmaceutical and Medicinal Chemistry, Heinrich Heine University Düsseldorf, Düsseldorf, Germany., Remke M; Division of Pediatric Neuro-Oncogenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany, and German Cancer Consortium (DKTK), partner site Essen/Düsseldorf, Düsseldorf, Germany siddhartha.mitra@cuanschutz.edu Marc.Remke@med.uni-duesseldorf.de.; Department of Pediatric Oncology, Hematology, and Clinical Immunology, Medical Faculty, University Hospital Düsseldorf, Düsseldorf, Germany; and DKTK, partner site Essen/Düsseldorf, Germany, Düsseldorf, Germany., Mitra S; Pediatrics, University of Colorado Denver, Aurora, Colorado, USA siddhartha.mitra@cuanschutz.edu Marc.Remke@med.uni-duesseldorf.de.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2023 Jan; Vol. 11 (1).
Autor:
Ahmadov U; Division of Pediatric Neuro-Oncogenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Consortium for Translational Cancer Research (DKTK), partner site Essen/Düsseldorf, Düsseldorf, Germany.; Department of Pediatric Oncology, Hematology, and Clinical Immunology, Medical Faculty, University Hospital Düsseldorf, Düsseldorf, Germany.; Department of Neuropathology, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany., Picard D; Division of Pediatric Neuro-Oncogenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Consortium for Translational Cancer Research (DKTK), partner site Essen/Düsseldorf, Düsseldorf, Germany.; Department of Pediatric Oncology, Hematology, and Clinical Immunology, Medical Faculty, University Hospital Düsseldorf, Düsseldorf, Germany.; Department of Neuropathology, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany., Bartl J; Division of Pediatric Neuro-Oncogenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Consortium for Translational Cancer Research (DKTK), partner site Essen/Düsseldorf, Düsseldorf, Germany.; Department of Pediatric Oncology, Hematology, and Clinical Immunology, Medical Faculty, University Hospital Düsseldorf, Düsseldorf, Germany.; Department of Neuropathology, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany., Silginer M; Department of Neurology, University Hospital and University of Zurich, Zurich, Switzerland., Trajkovic-Arsic M; Bridge Institute of Experimental Tumor Therapy, West German Cancer Center, University Medicine Essen, Essen, Germany.; Division of Solid Tumor Translational Oncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), partner site Essen, Heidelberg, Germany., Qin N; Division of Pediatric Neuro-Oncogenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Consortium for Translational Cancer Research (DKTK), partner site Essen/Düsseldorf, Düsseldorf, Germany.; Department of Pediatric Oncology, Hematology, and Clinical Immunology, Medical Faculty, University Hospital Düsseldorf, Düsseldorf, Germany.; Department of Neuropathology, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany., Blümel L; Division of Pediatric Neuro-Oncogenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Consortium for Translational Cancer Research (DKTK), partner site Essen/Düsseldorf, Düsseldorf, Germany.; Department of Pediatric Oncology, Hematology, and Clinical Immunology, Medical Faculty, University Hospital Düsseldorf, Düsseldorf, Germany.; Department of Neuropathology, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany., Wolter M; Department of Neuropathology, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany., Lim JKM; Department of Neuropathology, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany., Pauck D; Division of Pediatric Neuro-Oncogenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Consortium for Translational Cancer Research (DKTK), partner site Essen/Düsseldorf, Düsseldorf, Germany.; Department of Pediatric Oncology, Hematology, and Clinical Immunology, Medical Faculty, University Hospital Düsseldorf, Düsseldorf, Germany.; Department of Neuropathology, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany., Winkelkotte AM; Bridge Institute of Experimental Tumor Therapy, West German Cancer Center, University Medicine Essen, Essen, Germany.; Division of Solid Tumor Translational Oncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), partner site Essen, Heidelberg, Germany., Melcher M; Department of General Pediatrics, Neonatology and Pediatric Cardiology, University Hospital Düsseldorf, Düsseldorf, Germany., Langini M; Institute for Molecular Medicine I, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany.; Molecular Proteomics Laboratory (MPL), Biological-Medical Research Center (BMFZ), Heinrich Heine University, Düsseldorf, Germany., Marquardt V; Division of Pediatric Neuro-Oncogenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Consortium for Translational Cancer Research (DKTK), partner site Essen/Düsseldorf, Düsseldorf, Germany.; Department of Pediatric Oncology, Hematology, and Clinical Immunology, Medical Faculty, University Hospital Düsseldorf, Düsseldorf, Germany.; Department of Neuropathology, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany., Sander F; Division of Pediatric Neuro-Oncogenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Consortium for Translational Cancer Research (DKTK), partner site Essen/Düsseldorf, Düsseldorf, Germany.; Department of Pediatric Oncology, Hematology, and Clinical Immunology, Medical Faculty, University Hospital Düsseldorf, Düsseldorf, Germany.; Department of Neuropathology, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany., Stefanski A; Institute for Molecular Medicine I, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany.; Molecular Proteomics Laboratory (MPL), Biological-Medical Research Center (BMFZ), Heinrich Heine University, Düsseldorf, Germany., Steltgens S; Department of Neuropathology, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany., Hassiepen C; Department of Molecular Oncology, West German Cancer Center, University Hospital Essen, Essen, Germany., Kaufhold A; Division of Pediatric Neuro-Oncogenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Consortium for Translational Cancer Research (DKTK), partner site Essen/Düsseldorf, Düsseldorf, Germany.; Department of Pediatric Oncology, Hematology, and Clinical Immunology, Medical Faculty, University Hospital Düsseldorf, Düsseldorf, Germany.; Department of Neuropathology, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany., Meyer FD; Division of Pediatric Neuro-Oncogenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Consortium for Translational Cancer Research (DKTK), partner site Essen/Düsseldorf, Düsseldorf, Germany.; Department of Pediatric Oncology, Hematology, and Clinical Immunology, Medical Faculty, University Hospital Düsseldorf, Düsseldorf, Germany.; Department of Neuropathology, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany., Seibt A; Department of General Pediatrics, Neonatology and Pediatric Cardiology, University Hospital Düsseldorf, Düsseldorf, Germany., Kleinesudeik L; Institute for Experimental Cancer Research in Pediatrics, Goethe University Frankfurt, Frankfurt, Germany.; German Cancer Consortium (DKTK), Partner Site Frankfurt and German Cancer Research Center (DKFZ), Heidelberg, Germany., Hain A; Clinic for Gastroenterology, Hepatology, and Infectiology, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany., Münk C; Clinic for Gastroenterology, Hepatology, and Infectiology, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany., Knobbe-Thomsen CB; Department of Neuropathology, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany., Schramm A; Department of Molecular Oncology, West German Cancer Center, University Hospital Essen, Essen, Germany., Fischer U; Department of Pediatric Oncology, Hematology, and Clinical Immunology, Medical Faculty, University Hospital Düsseldorf, Düsseldorf, Germany., Leprivier G; Department of Neuropathology, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany., Stühler K; Institute for Molecular Medicine I, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany.; Molecular Proteomics Laboratory (MPL), Biological-Medical Research Center (BMFZ), Heinrich Heine University, Düsseldorf, Germany., Fulda S; Institute for Experimental Cancer Research in Pediatrics, Goethe University Frankfurt, Frankfurt, Germany.; German Cancer Consortium (DKTK), Partner Site Frankfurt and German Cancer Research Center (DKFZ), Heidelberg, Germany., Siveke JT; Bridge Institute of Experimental Tumor Therapy, West German Cancer Center, University Medicine Essen, Essen, Germany.; Division of Solid Tumor Translational Oncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), partner site Essen, Heidelberg, Germany., Distelmaier F; Department of General Pediatrics, Neonatology and Pediatric Cardiology, University Hospital Düsseldorf, Düsseldorf, Germany., Borkhardt A; Division of Pediatric Neuro-Oncogenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Consortium for Translational Cancer Research (DKTK), partner site Essen/Düsseldorf, Düsseldorf, Germany.; Department of Pediatric Oncology, Hematology, and Clinical Immunology, Medical Faculty, University Hospital Düsseldorf, Düsseldorf, Germany., Weller M; Department of Neurology, University Hospital and University of Zurich, Zurich, Switzerland., Roth P; Department of Neurology, University Hospital and University of Zurich, Zurich, Switzerland., Reifenberger G; Division of Pediatric Neuro-Oncogenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Consortium for Translational Cancer Research (DKTK), partner site Essen/Düsseldorf, Düsseldorf, Germany.; Department of Neuropathology, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany., Remke M; Division of Pediatric Neuro-Oncogenomics, German Cancer Research Center (DKFZ), Heidelberg, Germany. marc.remke@med.uni-duesseldorf.de.; German Consortium for Translational Cancer Research (DKTK), partner site Essen/Düsseldorf, Düsseldorf, Germany. marc.remke@med.uni-duesseldorf.de.; Department of Pediatric Oncology, Hematology, and Clinical Immunology, Medical Faculty, University Hospital Düsseldorf, Düsseldorf, Germany. marc.remke@med.uni-duesseldorf.de.; Department of Neuropathology, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany. marc.remke@med.uni-duesseldorf.de.
Publikováno v:
Cell death & disease [Cell Death Dis] 2021 Sep 28; Vol. 12 (10), pp. 885. Date of Electronic Publication: 2021 Sep 28.
Autor:
Prescher N; Institute of Molecular Medicine, Proteome Research, Medical Faculty and University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Universitätsstraße 1, 40225 Düsseldorf, Germany., Hänsch S; Department of Biology, Center for Advanced Imaging (CAi), Heinrich-Heine University Düsseldorf, Universitätsstraße 1, 40225 Düsseldorf, Germany., Knobbe-Thomsen CB; Department of Neuropathology, Heinrich-Heine University Düsseldorf and University Hospital, Universitätsstraße 1, 40225 Düsseldorf, Germany., Stühler K; Institute of Molecular Medicine, Proteome Research, Medical Faculty and University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Universitätsstraße 1, 40225 Düsseldorf, Germany; Molecular Proteomics Laboratory, Biomedical Research Centre (BMFZ), Heinrich-Heine University Düsseldorf, Universitätsstraße 1, 40225 Düsseldorf, Germany., Poschmann G; Institute of Molecular Medicine, Proteome Research, Medical Faculty and University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Universitätsstraße 1, 40225 Düsseldorf, Germany. Electronic address: Gereon.Poschmann@uni-duesseldorf.de.
Publikováno v:
Free radical biology & medicine [Free Radic Biol Med] 2021 May 01; Vol. 167, pp. 81-93. Date of Electronic Publication: 2021 Mar 10.
Autor:
Reich S; Biochemistry I, University of Regensburg, Regensburg, Germany., Nguyen CDL; Leibniz-Institut für Analytische Wissenschaften-ISAS-e.V., Dortmund, Germany., Has C; Leibniz-Institut für Analytische Wissenschaften-ISAS-e.V., Dortmund, Germany.; Institute for Clinical Chemistry and Laboratory Medicine, Technical University Dresden, Dresden, Germany., Steltgens S; Department of Neuropathology, Heinrich Heine University Düsseldorf, Düsseldorf, Germany., Soni H; Molecular Mechanisms of Tumor Invasion, German Cancer Research Center (DKFZ), Heidelberg, Germany., Coman C; Department of Analytical Chemistry, University of Vienna, Vienna, Austria., Freyberg M; Biochemistry I, University of Regensburg, Regensburg, Germany., Bichler A; Biochemistry I, University of Regensburg, Regensburg, Germany., Seifert N; Biochemistry I, University of Regensburg, Regensburg, Germany., Conrad D; Biochemistry I, University of Regensburg, Regensburg, Germany., Knobbe-Thomsen CB; Department of Neuropathology, Heinrich Heine University Düsseldorf, Düsseldorf, Germany., Tews B; Molecular Mechanisms of Tumor Invasion, German Cancer Research Center (DKFZ), Heidelberg, Germany.; AbbVie Deutschland GmbH & Co.KG, Wiesbaden, Germany., Toedt G; Computational Biology Unit, European Molecular Biology Laboratory (EMBL), Heidelberg, Germany., Ahrends R; Leibniz-Institut für Analytische Wissenschaften-ISAS-e.V., Dortmund, Germany. Robert.Ahrends@univie.ac.at.; Department of Analytical Chemistry, University of Vienna, Vienna, Austria. Robert.Ahrends@univie.ac.at., Medenbach J; Biochemistry I, University of Regensburg, Regensburg, Germany. Jan.Medenbach@ur.de.
Publikováno v:
Nature communications [Nat Commun] 2020 Jun 10; Vol. 11 (1), pp. 2936. Date of Electronic Publication: 2020 Jun 10.
Autor:
Kurniawan H; Experimental & Molecular Immunology, Department of Infection and Immunity, Luxembourg Institute of Health, 29 Rue Henri Koch, Esch-sur-Alzette, Luxembourg., Franchina DG; Experimental & Molecular Immunology, Department of Infection and Immunity, Luxembourg Institute of Health, 29 Rue Henri Koch, Esch-sur-Alzette, Luxembourg., Guerra L; Experimental & Molecular Immunology, Department of Infection and Immunity, Luxembourg Institute of Health, 29 Rue Henri Koch, Esch-sur-Alzette, Luxembourg., Bonetti L; Experimental & Molecular Immunology, Department of Infection and Immunity, Luxembourg Institute of Health, 29 Rue Henri Koch, Esch-sur-Alzette, Luxembourg., -Baguet LS; Experimental & Molecular Immunology, Department of Infection and Immunity, Luxembourg Institute of Health, 29 Rue Henri Koch, Esch-sur-Alzette, Luxembourg., Grusdat M; Experimental & Molecular Immunology, Department of Infection and Immunity, Luxembourg Institute of Health, 29 Rue Henri Koch, Esch-sur-Alzette, Luxembourg., Schlicker L; Braunschweig Integrated Center of Systems Biology (BRICS), Technische Universität Braunschweig, Rebenring 56, 38106 Braunschweig; Computational Biology of Infection Research, Helmholtz Centre for Infection Research, Inhoffenstraße 7, 38124 Braunschweig, Germany., Hunewald O; Allergy and Clinical Immunology, Department of Infection and Immunity, Luxembourg Institute of Health, 29 Rue Henri Koch, L-4354 Esch-sur-Alzette, Luxembourg., Dostert C; Experimental & Molecular Immunology, Department of Infection and Immunity, Luxembourg Institute of Health, 29 Rue Henri Koch, Esch-sur-Alzette, Luxembourg., Merz MP; Immune Endocrine Epigenetics Research Group, Department of Infection and Immunity, Luxembourg Institute of Health, 29 Rue Henri Koch, L-4354 Esch-sur-Alzette, Grand Duchy of Luxembourg., Binsfeld C; Experimental & Molecular Immunology, Department of Infection and Immunity, Luxembourg Institute of Health, 29 Rue Henri Koch, Esch-sur-Alzette, Luxembourg., Duncan GS; The Campbell Family Cancer Research Institute, Ontario Cancer Institute University Health Network, Toronto, ON, Canada., Farinelle S; Experimental & Molecular Immunology, Department of Infection and Immunity, Luxembourg Institute of Health, 29 Rue Henri Koch, Esch-sur-Alzette, Luxembourg., Nonnenmacher Y; Braunschweig Integrated Center of Systems Biology (BRICS), Technische Universität Braunschweig, Rebenring 56, 38106 Braunschweig; Computational Biology of Infection Research, Helmholtz Centre for Infection Research, Inhoffenstraße 7, 38124 Braunschweig, Germany., Haight J; The Campbell Family Cancer Research Institute, Ontario Cancer Institute University Health Network, Toronto, ON, Canada., Das Gupta D; Institute for Medical Microbiology and Hospital Hygiene, University of Marburg, Marburg, Germany., Ewen A; Experimental & Molecular Immunology, Department of Infection and Immunity, Luxembourg Institute of Health, 29 Rue Henri Koch, Esch-sur-Alzette, Luxembourg., Taskesen R; Departments of Medical Biophysics and Immunology, Faculty of Medicine, University of Toronto, Toronto, ON, Canada., Halder R; Luxembourg Centre for Systems Biomedicine, University of Luxembourg, 7 Avenue des Hauts Fourneaux, Esch-sur-Alzette, Luxembourg., Chen Y; Department of Environmental Health Sciences, Yale School of Public Health, New Haven, CT, USA., Jäger C; Luxembourg Centre for Systems Biomedicine, University of Luxembourg, 7 Avenue des Hauts Fourneaux, Esch-sur-Alzette, Luxembourg., Ollert M; Allergy and Clinical Immunology, Department of Infection and Immunity, Luxembourg Institute of Health, 29 Rue Henri Koch, L-4354 Esch-sur-Alzette, Luxembourg; Odense Research Center for Anaphylaxis (ORCA), Department of Dermatology and Allergy Center, Odense University Hospital, University of Southern Denmark, Odense, Denmark., Wilmes P; Luxembourg Centre for Systems Biomedicine, University of Luxembourg, 7 Avenue des Hauts Fourneaux, Esch-sur-Alzette, Luxembourg., Vasiliou V; Department of Environmental Health Sciences, Yale School of Public Health, New Haven, CT, USA., Harris IS; Department of Biomedical Genetics and Wilmot Cancer Institute, University of Rochester Medical Center, 601 Elmwood Ave, Rochester, New York, USA., Knobbe-Thomsen CB; Departments of Medical Biophysics and Immunology, Faculty of Medicine, University of Toronto, Toronto, ON, Canada., Turner JD; Immune Endocrine Epigenetics Research Group, Department of Infection and Immunity, Luxembourg Institute of Health, 29 Rue Henri Koch, L-4354 Esch-sur-Alzette, Grand Duchy of Luxembourg., Mak TW; The Campbell Family Cancer Research Institute, Ontario Cancer Institute University Health Network, Toronto, ON, Canada; Departments of Medical Biophysics and Immunology, Faculty of Medicine, University of Toronto, Toronto, ON, Canada; The University of Hong Kong, Hong Kong SAR, China., Lohoff M; Institute for Medical Microbiology and Hospital Hygiene, University of Marburg, Marburg, Germany., Meiser J; Cancer Metabolism Group, Department of Oncology, 84 Val Fleuri, Luxembourg, Luxembourg., Hiller K; Braunschweig Integrated Center of Systems Biology (BRICS), Technische Universität Braunschweig, Rebenring 56, 38106 Braunschweig; Computational Biology of Infection Research, Helmholtz Centre for Infection Research, Inhoffenstraße 7, 38124 Braunschweig, Germany., Brenner D; Experimental & Molecular Immunology, Department of Infection and Immunity, Luxembourg Institute of Health, 29 Rue Henri Koch, Esch-sur-Alzette, Luxembourg; Odense Research Center for Anaphylaxis (ORCA), Department of Dermatology and Allergy Center, Odense University Hospital, University of Southern Denmark, Odense, Denmark; Immunology & Genetics, Luxembourg Centre for Systems Biomedicine, University of Luxembourg, 7 Avenue des Hauts Fourneaux, Esch-sur-Alzette, Luxembourg. Electronic address: dirk.brenner@lih.lu.
Publikováno v:
Cell metabolism [Cell Metab] 2020 May 05; Vol. 31 (5), pp. 920-936.e7. Date of Electronic Publication: 2020 Mar 25.
Publikováno v:
Cancer research [Cancer Res] 2019 Nov 01; Vol. 79 (21), pp. 5681.